Cancer Management and Researchhttps://www.dovepress.com/feed/journal/55New articles released by Dove Press for Cancer Management and Researchen-us2026, Dove Pressangela@dovepress.com (Angela Jones)Dove Press Cancer Management and ResearchCancer Management and Researchhttps://www.dovepress.com/feed/journal/55https://www.dovepress.com/assets/img/addon/rss-banner.jpg140140Post-IMvigor011 Era: CtDNA-Guided Postoperative Adjuvant Treatment Stratification in Muscle-Invasive Bladder Cancerhttps://www.dovepress.com/post-imvigor011-era-ctdna-guided-postoperative-adjuvant-treatment-stra-peer-reviewed-fulltext-article-CMARCancer Management and ResearchFri, 10 Jul 2026 18:55:00 +1200https://doi.org/10.2147/CMAR.S609903A Novel Prognostic Model Based on Prognostic Nutritional Index and Systemic Immune-Inflammation Index for Cancer Patients Treated with Immune Checkpoint Inhibitorshttps://www.dovepress.com/a-novel-prognostic-model-based-on-prognostic-nutritional-index-and-sys-peer-reviewed-fulltext-article-CMARCancer Management and ResearchFri, 10 Jul 2026 05:25:00 +1200https://doi.org/10.2147/CMAR.S611679Cytotoxic Effect of Halimeda macroloba Crude Extract on Cervical Cancer Spheroid Cells via p-mTOR/mTOR, Apoptosis, and Ferroptosis Pathwayshttps://www.dovepress.com/cytotoxic-effect-of-halimeda-macroloba-crude-extract-on-cervical-cance-peer-reviewed-fulltext-article-CMARCancer Management and ResearchFri, 10 Jul 2026 03:55:00 +1200https://doi.org/10.2147/CMAR.S611650microRNA-139-3p Inhibits Malignant Behaviors of Laryngeal Cancer Cells via the KDM5B/SOX2 Axis and the Wnt/β-Catenin Pathway [Retraction]https://www.dovepress.com/retraction-microrna-139-3p-inhibits-malignant-behaviors-of-laryngeal-c-peer-reviewed-fulltext-article-CMARCancer Management and ResearchFri, 10 Jul 2026 02:30:00 +1200https://doi.org/10.2147/CMAR.S638585Construction and Validation of a Nomogram Prediction Model for Individualized Prediction of the Risk of Oral Infection in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy and Chemotherapyhttps://www.dovepress.com/construction-and-validation-of-a-nomogram-prediction-model-for-individ-peer-reviewed-fulltext-article-CMARCancer Management and ResearchFri, 10 Jul 2026 02:25:00 +1200https://doi.org/10.2147/CMAR.S603294Chlorpromazine versus Metoclopramide for Neurogenic Nausea and Vomiting in Incurable Patients with Gastrointestinal Tumors: A Prospective Observational Cohort Studyhttps://www.dovepress.com/chlorpromazine-versus-metoclopramide-for-neurogenic-nausea-and-vomitin-peer-reviewed-fulltext-article-CMARCancer Management and ResearchThu, 09 Jul 2026 15:37:00 +1200https://doi.org/10.2147/CMAR.S612989Inflammatory, Immune-Metabolic, and Vascular Biomarker Trajectories Across Treatment Modalities and Associations with Treatment-Related Complications in Oral Squamous Cell Carcinoma: A Prospective Study in Taiwanhttps://www.dovepress.com/inflammatory-immune-metabolic-and-vascular-biomarker-trajectories-acro-peer-reviewed-fulltext-article-CMARCancer Management and ResearchWed, 08 Jul 2026 19:33:00 +1200https://doi.org/10.2147/CMAR.S599334Systemic Inflammation Response Index, Albumin, and Hemoglobin-Albumin-Lymphocyte-Platelet Score for Stage-Stratified Esophageal Cancer Discrimination: A Retrospective Case-Control Studyhttps://www.dovepress.com/systemic-inflammation-response-index-albumin-and-hemoglobin-albumin-ly-peer-reviewed-fulltext-article-CMARCancer Management and ResearchWed, 08 Jul 2026 19:12:00 +1200https://doi.org/10.2147/CMAR.S614276Hippo-YAP/TAZ Signaling in Hematological Malignancies: Molecular Mechanisms, Pathway Crosstalk and Therapeutic Potentialhttps://www.dovepress.com/hippo-yaptaz-signaling-in-hematological-malignancies-molecular-mechani-peer-reviewed-fulltext-article-CMARCancer Management and ResearchTue, 07 Jul 2026 05:27:00 +1200https://doi.org/10.2147/CMAR.S618762The Interaction of PI3K/AKT/mTOR Pathway with the Tumor Microenvironment: A Dual Engine Driving Breast Cancer Progression and Reshaping Treatment Strategieshttps://www.dovepress.com/the-interaction-of-pi3kaktmtor-pathway-with-the-tumor-microenvironment-peer-reviewed-fulltext-article-CMARCancer Management and ResearchTue, 30 Jun 2026 21:35:00 +1200https://doi.org/10.2147/CMAR.S616696Research Progress of HER2 in Cervical Carcinomahttps://www.dovepress.com/research-progress-of-her2-in-cervical-carcinoma-peer-reviewed-fulltext-article-CMARCancer Management and ResearchFri, 26 Jun 2026 23:50:00 +1200https://doi.org/10.2147/CMAR.S613300Colorectal Cancer Progression and Bone Metastasis: Molecular Mechanisms, Tumor Microenvironment, and Tumor-Bone Crosstalkhttps://www.dovepress.com/colorectal-cancer-progression-and-bone-metastasis-molecular-mechanisms-peer-reviewed-fulltext-article-CMARCancer Management and ResearchFri, 26 Jun 2026 18:05:00 +1200https://doi.org/10.2147/CMAR.S579585Jianpi Rougan Method in Support of Lenvatinib Therapy: A Real-World Study on Maintaining Relative Dose Intensity and Mitigating Toxicity–Driven Discontinuation in Intermediate-to-Advanced HCChttps://www.dovepress.com/jianpi-rougan-method-in-support-of-lenvatinib-therapy-a-real-world-stu-peer-reviewed-fulltext-article-CMARCancer Management and ResearchThu, 25 Jun 2026 18:30:00 +1200https://doi.org/10.2147/CMAR.S603191Molecular Response to Treatment of Chronic Myeloid Leukemia at University Teaching Hospital of Kigali, Rwanda: One-Arm Open Label Prospective Observational Studyhttps://www.dovepress.com/molecular-response-to-treatment-of-chronic-myeloid-leukemia-at-univers-peer-reviewed-fulltext-article-CMARCancer Management and ResearchWed, 24 Jun 2026 18:50:00 +1200https://doi.org/10.2147/CMAR.S595861Common Bile Duct Diameter in Bladder Urothelial Carcinoma: A Case-Control Studyhttps://www.dovepress.com/common-bile-duct-diameter-in-bladder-urothelial-carcinoma-a-case-contr-peer-reviewed-fulltext-article-CMARCancer Management and ResearchWed, 24 Jun 2026 18:35:00 +1200https://doi.org/10.2147/CMAR.S580011Baseline Nutritional Indices as Prognostic Indicators in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma Treated with the PD-L1 Inhibitor KL-A167: A Secondary Analysis of the KL-A167 Trialhttps://www.dovepress.com/baseline-nutritional-indices-as-prognostic-indicators-in-patients-with-peer-reviewed-fulltext-article-CMARCancer Management and ResearchWed, 24 Jun 2026 03:25:00 +1200https://doi.org/10.2147/CMAR.S611346Combining Serum PVT1 Exon 4A and Exon 9 with Serum Prostate-Specific Antigen Shows Potential for Improving Identification and Risk Stratification of Prostate Cancerhttps://www.dovepress.com/combining-serum-pvt1-exon-4a-and-exon-9-with-serum-prostate-specific-a-peer-reviewed-fulltext-article-CMARCancer Management and ResearchTue, 23 Jun 2026 03:50:00 +1200https://doi.org/10.2147/CMAR.S604901PET-MR Examination in Diagnosing Bone Metastases in Prostate Cancerhttps://www.dovepress.com/pet-mr-examination-in-diagnosing-bone-metastases-in-prostate-cancer-peer-reviewed-fulltext-article-CMARCancer Management and ResearchFri, 19 Jun 2026 23:35:00 +1200https://doi.org/10.2147/CMAR.S572865Early versus Long-Term Post-Prostatectomy Incontinence Recovery Among Three Robotic-Assisted Radical Prostatectomy Techniques: A Retrospective Cohort Studyhttps://www.dovepress.com/early-versus-long-term-post-prostatectomy-incontinence-recovery-among--peer-reviewed-fulltext-article-CMARCancer Management and ResearchThu, 18 Jun 2026 17:10:00 +1200https://doi.org/10.2147/CMAR.S604780Exploratory Pilot Multi-Omics Profiling of Gut Microbiota and Metabolic Features in Patients with Prolactinomahttps://www.dovepress.com/exploratory-pilot-multi-omics-profiling-of-gut-microbiota-and-metaboli-peer-reviewed-fulltext-article-CMARCancer Management and ResearchTue, 16 Jun 2026 22:45:00 +1200https://doi.org/10.2147/CMAR.S608026Berberine from Tibetan Medicine Dracocephalum tanguticum Maxim Suppresses Colorectal Tumor Growth and Inhibits CD8⁺ T Cells Ferroptosis via the NRF2–SLC7A11–GPX4 Axishttps://www.dovepress.com/berberine-from-tibetan-medicine-dracocephalum-tanguticum-maxim-suppres-peer-reviewed-fulltext-article-CMARCancer Management and ResearchTue, 16 Jun 2026 03:00:00 +1200https://doi.org/10.2147/CMAR.S600327CLDN18.2-Directed Therapeutics in Gastric and Gastroesophageal Junction Adenocarcinoma: Biomarker Assessment, Expression Dynamics, and Treatment Sequencinghttps://www.dovepress.com/cldn182-directed-therapeutics-in-gastric-and-gastroesophageal-junction-peer-reviewed-fulltext-article-CMARCancer Management and ResearchMon, 15 Jun 2026 21:35:00 +1200https://doi.org/10.2147/CMAR.S611187Preoperative Lactate Dehydrogenase-to-Albumin Ratio and Overall Survival in Gastric Cancer: Stage-Specific Prognostic Implicationshttps://www.dovepress.com/preoperative-lactate-dehydrogenase-to-albumin-ratio-and-overall-surviv-peer-reviewed-fulltext-article-CMARCancer Management and ResearchMon, 15 Jun 2026 17:50:00 +1200https://doi.org/10.2147/CMAR.S614341Outcomes of Subtotal Colectomy with Ileorectal Anastomosis and Intensive Endoscopic Surveillance in Familial Adenomatous Polyposis: A Case Serieshttps://www.dovepress.com/outcomes-of-subtotal-colectomy-with-ileorectal-anastomosis-and-intensi-peer-reviewed-fulltext-article-CMARCancer Management and ResearchFri, 12 Jun 2026 03:45:00 +1200https://doi.org/10.2147/CMAR.S611177Development and Validation of a Nomogram Integrating Body Composition and Inflammatory Markers to Predict Concurrent Chemoradiotherapy Response in Locally Advanced Cervical Cancerhttps://www.dovepress.com/development-and-validation-of-a-nomogram-integrating-body-composition--peer-reviewed-fulltext-article-CMARCancer Management and ResearchThu, 11 Jun 2026 20:05:00 +1200https://doi.org/10.2147/CMAR.S600310Association Between Blood Transfusion and Survival Outcomes in Metastatic Cutaneous Melanoma Treated with Nivolumabhttps://www.dovepress.com/association-between-blood-transfusion-and-survival-outcomes-in-metasta-peer-reviewed-fulltext-article-CMARCancer Management and ResearchFri, 05 Jun 2026 18:00:00 +1200https://doi.org/10.2147/CMAR.S611126Assessing Invasiveness of Ground-Glass Nodules Using Ternary-Class CT Radiomics Models: A Multi-Center Study with SHAP Explanationshttps://www.dovepress.com/assessing-invasiveness-of-ground-glass-nodules-using-ternary-class-ct--peer-reviewed-fulltext-article-CMARCancer Management and ResearchFri, 05 Jun 2026 17:55:00 +1200https://doi.org/10.2147/CMAR.S602730IRF1 Inhibits the Proliferation and Metastasis of Colorectal Cancer by Suppressing the RAS-RAC1 Pathway [Retraction]https://www.dovepress.com/retraction-irf1-inhibits-the-proliferation-and-metastasis-of-colorecta-peer-reviewed-fulltext-article-CMARCancer Management and ResearchFri, 05 Jun 2026 04:30:00 +1200https://doi.org/10.2147/CMAR.S629834Association Between ABO Blood Group and Survival in Early-Stage Colon Cancer: A Single-Center Retrospective Cohort Analysishttps://www.dovepress.com/association-between-abo-blood-group-and-survival-in-early-stage-colon--peer-reviewed-fulltext-article-CMARCancer Management and ResearchFri, 05 Jun 2026 02:05:00 +1200https://doi.org/10.2147/CMAR.S605315Comparative Efficacy of Fosnetupitant and Fosaprepitant for Delayed Vomiting in Patients Receiving Irinotecan-Oxaliplatin Combination Chemotherapy: A Retrospective Propensity Score-Matched Studyhttps://www.dovepress.com/comparative-efficacy-of-fosnetupitant-and-fosaprepitant-for-delayed-vo-peer-reviewed-fulltext-article-CMARCancer Management and ResearchThu, 04 Jun 2026 16:50:00 +1200https://doi.org/10.2147/CMAR.S579955